Champlain Investment Partners, LLC Bio Rad Laboratories, Inc. Transaction History

Champlain Investment Partners, LLC

$15.8 Billion
Q3 2024

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$359.49 - $486.4 $14 Million - $19 Million	39,065 Added 17.95%	256,730 $97.3 Million
Q1 2023 May 12, 2023	SELL	$418.69 - $503.0 $443,811 - $533,180	-1,060 Reduced 0.48%	217,665 $104 Million
Q4 2022 Feb 13, 2023	SELL	$351.71 - $456.01 $1.75 Million - $2.26 Million	-4,965 Reduced 2.22%	218,725 $92 Million
Q3 2022 Nov 14, 2022	SELL	$412.59 - $563.26 $1.99 Million - $2.71 Million	-4,820 Reduced 2.11%	223,690 $93.3 Million
Q2 2022 Aug 12, 2022	SELL	$463.67 - $597.16 $7.42 Million - $9.55 Million	-15,995 Reduced 6.54%	228,510 $113 Million
Q1 2022 May 12, 2022	SELL	$524.57 - $735.42 $141,633 - $198,563	-270 Reduced 0.11%	244,505 $138 Million
Q4 2021 Feb 10, 2022	SELL	$708.84 - $794.68 $4.25 Million - $4.77 Million	-6,000 Reduced 2.39%	244,775 $185 Million
Q3 2021 Nov 12, 2021	SELL	$657.71 - $825.77 $6.93 Million - $8.7 Million	-10,540 Reduced 4.03%	250,775 $187 Million
Q2 2021 Aug 12, 2021	BUY	$576.64 - $649.04 $1.1 Million - $1.24 Million	1,915 Added 0.74%	261,315 $168 Million
Q1 2021 May 13, 2021	BUY	$547.01 - $662.35 $14.3 Million - $17.3 Million	26,155 Added 11.21%	259,400 $148 Million
Q4 2020 Feb 12, 2021	BUY	$510.68 - $643.45 $13 Million - $16.3 Million	25,375 Added 12.21%	233,245 $136 Million
Q3 2020 Nov 13, 2020	BUY	$454.43 - $535.6 $2.6 Million - $3.06 Million	5,720 Added 2.83%	207,870 $107 Million
Q2 2020 Aug 13, 2020	BUY	$334.87 - $493.06 $33.3 Million - $49 Million	99,425 Added 96.79%	202,150 $91.3 Million
Q1 2020 May 14, 2020	BUY	$320.01 - $409.07 $32.9 Million - $42 Million	102,725 New	102,725 $36 Million

Others Institutions Holding BIO

# of Institutions

457

Shares Held

18.2M

Call Options Held

19.5K

Put Options Held

13.9K

View Full List

About BIO-RAD LABORATORIES, INC.

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.38B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

More about BIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Champlain Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Champlain Investment Partners, LLC with notifications on news.

Account